CV Lattes
ORCID
Google Scholar Citations
Universidade Federal do ABC (UFABC). Centro de Ciências Naturais e Humanas (CCNH) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Ciências Biológicas from Pontifícia Universidade Católica de Campinas (2005), master's at Tecnologia Bioquímico-Farmacêutica from Universidade de São Paulo (2008), doctorate at Ciências from Universidade de São Paulo (2012) and doctorate at Ingegneria Chimica, dei Materiali e di Processi from Università degli Studi di Genova (2012). Has experience in Microbiology, focusing on Applied Microbiology, acting on the following subjects: spirulina (arthrospira) plantesis, chlamydomonas reinhardtii, fed-batch process, recombinant protein and tubular photobioreactor. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The biopharmaceuticals' production and commercialization are directly related to the process scale-up and cost for the entire process up to the final product. This is especially true for complex molecules that are already difficult to produce by using the currently available commercial production platforms. The mammalian cell culture technology, even though produces primarily over 130 com…
Genetic editing techniques made it possible for several proteins to be expressed heterologously. Currently, many proteins/peptides have already been produced recombinantly, using vectors such as: bacteria, yeast, mammalian cells, insect and plant cells. Complex recombinant biological medicines only benefit from a portion of these possible platforms, with the predominance of the use of mam…
The use of Chlamydomonas reinhardtii for the accumulation of recombinant proteins has already been demonstrated by different researchers working with microalgal genetic engineering, however, there are proteins that have not yet been tested. Among them are some biological products that were, in 2015, considered as some of the priority medicines for the SUS (Unified Health System) in Brazil…
Chlamydomonas reinhardtii has been studied and used for accumulation of recombinant proteins. There are several therapeutic proteins of national interest that can be produced on this low cost microalgae platform. Filgrastime is a biological medicine that resembles the natural G-CSF (Granulocytic Colony-Stimulating Factor) of the human organism, acting to reduce the chances of infection in…
(Only some records are available in English at this moment)
| 1 / 1 | Completed research grants |
| 6 / 6 | Completed scholarships in Brazil |
| 7 / 7 | All research grants and scholarships |
| Associated processes | |